Loading
Medical oncologist who co-directs NCT/UCC Dresden and co-leads the NCT/DKFZ MASTER precision oncology programme for rare and young-onset cancers.
Hanno Glimm is a Managing Director of the National Center for Tumor Diseases (NCT/UCC) Dresden and heads its Department of Translational Medical Oncology. He co-leads the NCT/DKFZ MASTER programme, which applies whole-genome and transcriptome sequencing to guide treatment of patients with rare cancers and younger adults, and has published on hereditary cancer predisposition detected through comprehensive genomic profiling. His role is listed on the NCT/UCC Direktorium page.
Shares NCT/UCC Dresden, University Hospital Carl Gustav Carus and the tags leadership, clinician-scientist.
Shares Deutsches Netzwerk für Personalisierte Medizin and the tags leadership, clinician-scientist.
Shares NCT/UCC Dresden, University Hospital Carl Gustav Carus and the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist, precision oncology.
Shares the tags leadership, clinician-scientist, cancer genomics.
Shares the tags leadership, clinician-scientist, precision oncology.
Shares the tags leadership, clinician-scientist, precision oncology.
Shares the tags leadership, clinician-scientist, precision oncology.